Clinical Trial Update: Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy and cisplatin with or without surgery for stage III-IV oropharyngeal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Tongue Cancer
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx | Phase 2 | Status: WITHDRAWN